Studies have shown that diabetes and ischemia increase AR activity in hearts (76, 148) and that blockade of AR with ARI zopolrestat or sorbinil was found to improve cardiac glucose metabolism and to dramatically reduce acute ischemia-reperfusion-induced cardiac damage in diabetic rat hearts and in non-diabetic rat and rabbit hearts (76, 143–145). Here, AR is linked to diabetes mellitus.